Rangeley Capital »

Exelixis shares owned by Rangeley Capital

Quarter-by-quarter ownership of Exelixis (EXEL) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Exelixis

Tip: Access up to 7 years of quarterly data

All positions including Exelixis held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exelixis by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $219k 5.0k 43.83

More positions owned by Rangeley Capital

Warner Bros Discovery Com Ser A Call Option (WBD)
Golden Entmt (GDEN)
Calumet (CLMT)
Prothena Corp SHS (PRTA)
Yext (YEXT)
Arvinas Ord (ARVN)
Arbutus Biopharma (ABUS)
Avidity Biosciences Ord (RNA)
Repare Therapeutics Ord
Kennedy-Wilson Holdings (KW)
Seaport Entmt Group Common Stock (SEG)
Delek Us Holdings (DK)
Berto Acquisition Corp Ord Shs (TACO)
Grindr (GRND)
Plymouth Indl Reit

View all positions for Rangeley Capital

Top funds holding Exelixis

BlackRock
Vanguard Group
Farallon Capital Management
Renaissance Technologies
State Street Corporation
AQR Capital Management
Hanna Zanoni
LSV Asset Management
Geode Capital Management
Invesco
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
UBS Group
Assetmark
Caisse de depot et placement du Quebec

View all funds holding Exelixis